Predicting Biowarfare Agents Takes on Priority

The recent targeting of individuals and groups with the anthrax bacterium (Bacillus anthracis) has heightened the concern of the global community to bioterrorism. Unfortunately, the particular anthrax threat, and the responses discussed publicly, represent the tip of the iceberg. The anthrax bacterium cannot be transmitted through casual contact and is susceptible to antibiotics. In general, methods for anthrax prevention, detection, and treatment exist. Of far greater concern are readily transm

Written byRonald Kostoff
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Although only a limited number of viruses are considered suitable as biowarfare agents, a greater number might be made suitable through genetic engineering or other modifications. Those viral agents that have not been recognized previously as credible biowarfare agents pose a special threat, because their use would contain the element of surprise. For such agents, there would be no vaccines for prevention, no detection, and perhaps no therapies, and the potential destructive consequences would be far greater than those of the anthrax bacterium.

A recently published study,1 that used a text-mining variant known as literature-based discovery,2,3 identified viruses that could be considered as potential candidates for biowarfare agents. Generically, the study examined publicly available knowledge on different facets of biowarfare agents found in non-overlapping, highly specialized literatures and integrated these disparate literatures to identify viruses that had high potential as candidate biowarfare agents.

Specifically, the study postulated that biowarfare agents ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies